Campbell & Co. Investment Adviser »

Aurinia Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $334k 30k 11.05
2025-06-30 $337k 40k 8.47
2025-03-31 $354k 44k 8.04
2024-03-31 $1.2M 237k 5.01

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Vanguard Group
Geode Capital Management
Marshall Wace
Renaissance Technologies
Two Sigma Investments
Jacobs Levy Equity Management
Jane Street
Qube Research & Technologies
Henderson Group

View all funds holding Aurinia Pharmaceuticals